Journal article
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
Actions
Access Document
- Files:
-
-
(pdf, 3.0MB)
-
- Publisher copy:
- 10.1371/journal.pmed.0050227
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ "German Research Foundation (DFG)", "Kenyan Medical Research Institute"
More from this funder
Funding agency for:
Steffen Borrmann
+ "Wellcome Trust", "Kenyan Medical Research Institute"
More from this funder
Funding agency for:
Robert W. Snow
+ "Wellcome Trust", "Kenyan Medical Research Institute"
More from this funder
Funding agency for:
Nicholas J. White
Bibliographic Details
- Publisher:
- Public Library of Science Publisher's website
- Journal:
- PLoS Medicine Journal website
- Volume:
- 5
- Issue:
- 11
- Pages:
- Article: e227
- Publication date:
- 2008-11-05
- DOI:
- EISSN:
-
1549-1676
- ISSN:
-
1549-1277
- URN:
-
uuid:a830990b-e015-4f00-8b57-63ebd2036141
- Local pid:
- ora:2505
Item Description
- Language:
- English
- Keywords:
- Subjects:
Terms of use
- Copyright holder:
- Borrmann et al.
- Copyright date:
- 2008
- Notes:
- Citation: Borrmann, S. et al. (2008). 'Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria', PLoS Medicine, 5(11), e227. [Available at http://medicine.plosjournals.org]. © 2008 Borrmann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
If you are the owner of this record, you can report an update to it here: Report update to this record